(Q80738467)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

Raghuvir R. S. Pissurlenkar

3 January 2020

author

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mushtaque S Shaikh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Evans C. Coutinho

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

4 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Modeling

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1047-1071

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00894-007-0227-2

3 January 2020

exact match

0 references

1 reference

12 December 2020

Two highly conserved glutamic acid residues in the predicted β propeller domain of dipeptidyl peptidase IV are required for its enzyme activity

1 reference

12 December 2020

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

1 reference

12 December 2020

Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry

1 reference

12 December 2020

Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.

1 reference

12 December 2020

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

1 reference

12 December 2020

The reversed binding of beta-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitors.

1 reference

12 December 2020

Identification of the active site residues in dipeptidyl peptidase IV by affinity labeling and site-directed mutagenesis

1 reference

12 December 2020

In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.

1 reference

12 December 2020

Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)

1 reference

12 December 2020

The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice

1 reference

12 December 2020

3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents

1 reference

12 December 2020

Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin,

1 reference

12 December 2020

Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog

1 reference

12 December 2020

Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma

1 reference

12 December 2020

Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma.

1 reference

12 December 2020

Potent and selective proline derived dipeptidyl peptidase IV inhibitors

1 reference

12 December 2020

Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes

1 reference

12 December 2020

Discovery of potent and selective orally bioavailable beta-substituted phenylalanine derived dipeptidyl peptidase IV inhibitors

1 reference

12 December 2020

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

1 reference

12 December 2020

Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes

1 reference

12 December 2020

Gastric inhibitory polypeptide: the neglected incretin revisited

1 reference

12 December 2020

Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo

1 reference

12 December 2020

Incretin mimetics and dipeptidyl peptidase-IV inhibitors: a review of emerging therapies for type 2 diabetes

1 reference

12 December 2020

Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase

1 reference

12 December 2020

Discovery of potent and selective beta-homophenylalanine based dipeptidyl peptidase IV inhibitors

1 reference

12 December 2020

Comparative residue interaction analysis (CoRIA): a 3D-QSAR approach to explore the binding contributions of active site residues with ligands

1 reference

12 December 2020

The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism

1 reference

12 December 2020

A model of the active site of dipeptidyl peptidase IV predicted by comparative molecular field analysis and molecular modelling simulations

1 reference

12 December 2020

Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA

1 reference

12 December 2020

A CoMFA study of COX-2 inhibitors with receptor based alignment

1 reference

12 December 2020

Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells

1 reference

12 December 2020

Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study

1 reference

12 December 2020

Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide

1 reference

12 December 2020

Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus

1 reference

12 December 2020

Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model

1 reference

12 December 2020

New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors

1 reference

12 December 2020

Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase

1 reference

12 December 2020

A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma

1 reference

12 December 2020

(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

1 reference

12 December 2020

Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors

1 reference

12 December 2020

The 3D structure of rat DPPIV/CD26 as obtained by cryo-TEM and single particle analysis

1 reference

12 December 2020

Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV.

1 reference

12 December 2020

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes

1 reference

12 December 2020

Structure-activity studies of glucagon-like peptide-1.

1 reference

12 December 2020

Approaches to Measure Chemical Similarity– a Review

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/QSAR.200330831

10.1007/S00894-007-0227-2

18 January 2024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17676345%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference